These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


216 related items for PubMed ID: 17851087

  • 1. Prospective study of interleukin-6 and the risk of malignant ventricular tachyarrhythmia in ICD-recipients--a pilot study.
    Streitner F, Kuschyk J, Veltmann C, Brueckmann M, Streitner I, Brade J, Neumaier M, Bertsch T, Schumacher B, Borggrefe M, Wolpert C.
    Cytokine; 2007 Oct; 40(1):30-4. PubMed ID: 17851087
    [Abstract] [Full Text] [Related]

  • 2. Role of proinflammatory markers and NT-proBNP in patients with an implantable cardioverter-defibrillator and an electrical storm.
    Streitner F, Kuschyk J, Veltmann C, Ratay D, Schoene N, Streitner I, Brueckmann M, Schumacher B, Borggrefe M, Wolpert C.
    Cytokine; 2009 Sep; 47(3):166-72. PubMed ID: 19604708
    [Abstract] [Full Text] [Related]

  • 3. Predictors of VT/VF-occurrence in ICD patients: results from the PROFIT-Study.
    Klein G, Lissel C, Fuchs AC, Gardiwal A, Oswald H, Desousa M, Pichlmaier AM, Lichtinghagen R, Geerlings H, Lippolt P, Niehaus M, Drexler H, Korte T.
    Europace; 2006 Aug; 8(8):618-24. PubMed ID: 16864615
    [Abstract] [Full Text] [Related]

  • 4. Right ventricular pacing is an independent predictor for ventricular tachycardia/ventricular fibrillation occurrence and heart failure events in patients with an implantable cardioverter-defibrillator.
    Gardiwal A, Yu H, Oswald H, Luesebrink U, Ludwig A, Pichlmaier AM, Drexler H, Klein G.
    Europace; 2008 Mar; 10(3):358-63. PubMed ID: 18308756
    [Abstract] [Full Text] [Related]

  • 5. Predictive value of ventricular arrhythmia inducibility for subsequent ventricular tachycardia or ventricular fibrillation in Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients.
    Daubert JP, Zareba W, Hall WJ, Schuger C, Corsello A, Leon AR, Andrews ML, McNitt S, Huang DT, Moss AJ, MADIT II Study Investigators.
    J Am Coll Cardiol; 2006 Jan 03; 47(1):98-107. PubMed ID: 16386671
    [Abstract] [Full Text] [Related]

  • 6. Gender differences in ventricular arrhythmia recurrence in patients with coronary artery disease and implantable cardioverter-defibrillators.
    Lampert R, McPherson CA, Clancy JF, Caulin-Glaser TL, Rosenfeld LE, Batsford WP.
    J Am Coll Cardiol; 2004 Jun 16; 43(12):2293-9. PubMed ID: 15193696
    [Abstract] [Full Text] [Related]

  • 7. Induction of ventricular fibrillation rather than ventricular tachycardia predicts tachyarrhythmia recurrences in patients with idiopathic dilated cardiomyopathy and implantable cardioverter defibrillator for secondary prophylaxis.
    Rolf S, Haverkamp W, Borggrefe M, Breithardt G, Bocker D.
    Europace; 2009 Mar 16; 11(3):289-96. PubMed ID: 19095687
    [Abstract] [Full Text] [Related]

  • 8. QT interval variability and spontaneous ventricular tachycardia or fibrillation in the Multicenter Automatic Defibrillator Implantation Trial (MADIT) II patients.
    Haigney MC, Zareba W, Gentlesk PJ, Goldstein RE, Illovsky M, McNitt S, Andrews ML, Moss AJ, Multicenter Automatic Defibrillator Implantation Trial II investigators.
    J Am Coll Cardiol; 2004 Oct 06; 44(7):1481-7. PubMed ID: 15464332
    [Abstract] [Full Text] [Related]

  • 9. Driving and implantable cardioverter-defibrillator shocks for ventricular arrhythmias: results from the TOVA study.
    Albert CM, Rosenthal L, Calkins H, Steinberg JS, Ruskin JN, Wang P, Muller JE, Mittleman MA, TOVA Investigators.
    J Am Coll Cardiol; 2007 Dec 04; 50(23):2233-40. PubMed ID: 18061071
    [Abstract] [Full Text] [Related]

  • 10. Characteristics and relevance of clustering ventricular arrhythmias in defibrillator recipients.
    Stuber T, Eigenmann C, Delacrétaz E.
    Pacing Clin Electrophysiol; 2005 Jul 04; 28(7):702-7. PubMed ID: 16008807
    [Abstract] [Full Text] [Related]

  • 11. Factors influencing appropriate firing of the implanted defibrillator for ventricular tachycardia/fibrillation: findings from the Multicenter Automatic Defibrillator Implantation Trial II (MADIT-II).
    Singh JP, Hall WJ, McNitt S, Wang H, Daubert JP, Zareba W, Ruskin JN, Moss AJ, MADIT-II Investigators.
    J Am Coll Cardiol; 2005 Nov 01; 46(9):1712-20. PubMed ID: 16256874
    [Abstract] [Full Text] [Related]

  • 12. Depression as a predictor for appropriate shocks among patients with implantable cardioverter-defibrillators: results from the Triggers of Ventricular Arrhythmias (TOVA) study.
    Whang W, Albert CM, Sears SF, Lampert R, Conti JB, Wang PJ, Singh JP, Ruskin JN, Muller JE, Mittleman MA, TOVA Study Investigators.
    J Am Coll Cardiol; 2005 Apr 05; 45(7):1090-5. PubMed ID: 15808769
    [Abstract] [Full Text] [Related]

  • 13. QRS duration does not predict occurrence of ventricular tachyarrhythmias in patients with implanted cardioverter-defibrillators.
    Buxton AE, Sweeney MO, Wathen MS, Josephson ME, Otterness MF, Hogan-Miller E, Stark AJ, Degroot PJ, PainFREE Rx II Investigators.
    J Am Coll Cardiol; 2005 Jul 19; 46(2):310-6. PubMed ID: 16022960
    [Abstract] [Full Text] [Related]

  • 14. Relationship between New York Heart Association class change and ventricular tachyarrhythmia occurrence in patients treated with cardiac resynchronization plus defibrillator.
    Lepillier A, Piot O, Gerritse B, Copie X, Lavergne T, Paziaud O, Lascault G, Waintraub X, Otmani A, Le Heuzey JY.
    Europace; 2009 Jan 19; 11(1):80-5. PubMed ID: 18952828
    [Abstract] [Full Text] [Related]

  • 15. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study.
    Wilkoff BL, Williamson BD, Stern RS, Moore SL, Lu F, Lee SW, Birgersdotter-Green UM, Wathen MS, Van Gelder IC, Heubner BM, Brown ML, Holloman KK, PREPARE Study Investigators.
    J Am Coll Cardiol; 2008 Aug 12; 52(7):541-50. PubMed ID: 18687248
    [Abstract] [Full Text] [Related]

  • 16. Ventricular arrhythmia inducibility predicts subsequent ICD activation in nonischemic cardiomyopathy patients: a DEFINITE substudy.
    Daubert JP, Winters SL, Subacius H, Berger RD, Ellenbogen KA, Taylor SG, Schaechter A, Howard A, Kadish A, Defibrillators In Nonischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators.
    Pacing Clin Electrophysiol; 2009 Jun 12; 32(6):755-61. PubMed ID: 19545338
    [Abstract] [Full Text] [Related]

  • 17. Significance of inducible ventricular flutter/fibrillation in risk stratification in patients with coronary artery disease.
    Matsushita T, Chun S, Liem LB, Friday KJ, Sung RJ.
    Int J Cardiol; 2004 Mar 12; 94(1):67-71. PubMed ID: 14996477
    [Abstract] [Full Text] [Related]

  • 18. Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator.
    Moss AJ, Greenberg H, Case RB, Zareba W, Hall WJ, Brown MW, Daubert JP, McNitt S, Andrews ML, Elkin AD, Multicenter Automatic Defibrillator Implantation Trial-II (MADIT-II) Research Group.
    Circulation; 2004 Dec 21; 110(25):3760-5. PubMed ID: 15583079
    [Abstract] [Full Text] [Related]

  • 19. Differences in mechanisms and outcomes of syncope in patients with coronary disease or idiopathic left ventricular dysfunction as assessed by electrophysiologic testing.
    Brembilla-Perrot B, Suty-Selton C, Beurrier D, Houriez P, Nippert M, de la Chaise AT, Louis P, Claudon O, Andronache M, Abdelaal A, Sadoul N, Juillière Y.
    J Am Coll Cardiol; 2004 Aug 04; 44(3):594-601. PubMed ID: 15358027
    [Abstract] [Full Text] [Related]

  • 20. Reduction in ventricular tachyarrhythmias with statins in the Multicenter Automatic Defibrillator Implantation Trial (MADIT)-II.
    Vyas AK, Guo H, Moss AJ, Olshansky B, McNitt SA, Hall WJ, Zareba W, Steinberg JS, Fischer A, Ruskin J, Andrews ML, MADIT-II Research Group.
    J Am Coll Cardiol; 2006 Feb 21; 47(4):769-73. PubMed ID: 16487843
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.